Navigation Links
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Date:11/24/2008

s clearly support naproxcinod's non-detrimental blood pressure profile

The blood pressure data for naproxcinod 750 mg bid were consistent with those obtained in the 301 and 302 studies. Blood pressure was measured using standardized and controlled office blood pressure measurements (OBPM) at baseline and at weeks 2, 6 and 13 (see NOTE). At all time points, the patients treated with naproxcinod 750 mg bid showed a very similar blood pressure profile to those on placebo. In addition, naproxcinod 750 mg bid showed a clear reduction in systolic and diastolic blood pressure (SBP and DBP) compared to naproxen 500 mg bid at all time points. No stand alone statistical analysis of the blood pressure data from the 303 study was pre-specified.

As planned, NicOx will pool the blood pressure data from the three phase 3 studies (301, 302 and 303) according to a prospectively designed protocol that has been submitted to the FDA. The Company will disclose the top-line results of the pre-specified statistical analysis on the pooled data in the coming weeks.

Naproxcinod and placebo show the same gastrointestinal (GI) adverse event rate

Naproxcinod 750 mg bid showed good overall safety and tolerability. The percentage of patients who experienced one or more GI adverse events was the same for placebo and naproxcinod 750 mg bid at 15.5%, compared to 19.2% for naproxen 500 mg bid. In terms of the percentage of patients who experienced at least one adverse event overall, this was lower for naproxcinod 750 mg than naproxen 500 mg bid. There was not a single serious cardiovascular or serious GI adverse event in the naproxcinod arm during the 13 weeks of the 303 study, in contrast to the placebo and naproxen 500 mg bid arms.

Pascal Pfister MD, Chief Scientific Officer and Head of Research and Development at NicOx, commented: "We believe these are extremely good results, with naproxcinod demonstrating cl
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

13611

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... its 2014 second quarter financial results on Tuesday, August ... Company management will host a live audio webcast immediately ... to provide a business and financial update and discuss ... may access the live audio webcast via the Investors ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 22, 2014 Legislation backed by the ... Local Pharmacies Act of 2014") championing so-called "any ... undermine the availability of lower cost preferred pharmacy ... over the next 10 years, according to new ... Pharmaceutical Care Management Association (PCMA). The ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... 2011 West Pharmaceutical Services, Inc. (NYSE: WST ... investor conferences. Management will attend the 9th Annual ... NY.  Management will present an overview of West,s business and ... Management will also attend the UBS 2011 Global ...
... 2011 Prescription monitoring laboratory and clinical partner ... its Safe Use Treatment Monitoring Solution™. Consistent with ... compliant with the FDA,s Opioid Risk and Evaluation ... for controlled substances.  The program aims to support ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2
(Date:7/22/2014)... Africa (PRWEB) July 23, 2014 It all ... in an attempt to find common ground. Willem de Liefde ... the crossroads of their lives or careers. , Willem wrote ... deeper and look beyond the surface of things. It is ... future, driven by care and commitment. , This book represents ...
(Date:7/22/2014)... Los Angeles, CA (PRWEB) July 22, 2014 ... is expected to increase in size through 2022, according ... ways to improve their appearance can benefit from a ... eye serum review for women is now available at ... to access and includes instant links to many of ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Mona Khan ... certification on August 15th & 16th, 2014, at the ... only structured and nationally accredited Bollywood workout was launched ... by the globally appealing Bollywood culture, Bombay Jam® is ... easy to follow and designed with authentic Bollywood flavor. ...
(Date:7/22/2014)... Dr. Dental is excited to announce the redesign ... in mind, one of the main differences from the old ... navigation very easy. Dr. Dental is renowned for having exceptional ... dentist affordable, convenient and fun, and the new website mirrors ... appointment scheduling system right on the home page where a ...
(Date:7/22/2014)... Va. (PRWEB) July 22, 2014 ... 10, at the Ronald Reagan Building and International ... Forward: Warriors, Military Families and Civilian Communities,” will ... (registration opens at 7:30 a.m.) and cohosted by ... the National Defense Industrial Association (NDIA). USAA is ...
Breaking Medicine News(10 mins):Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3Health News:Dr. Dental Reveals Exciting New Website 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3
... Elbit Imaging Ltd.,(Nasdaq: EMITF ) ("EI" or ... of 2008., Loss for the first quarter of ... of which loss of NIS 27.3 million,(approximately US$ 7.7 ... while profit of NIS 23.8 million (approximately US$ 6.7,million) ...
... May 29 Subjects with type 1 or ... more frequently and,use the results to adjust treatment ... collection of state-of-the-art reports that,comprise a Special Supplement ... of Diabetes Technology & Therapeutics, a peer-reviewed journal ...
... New research from the Oregon Health & Science ... a wellspring of hope to many patients. , Researchers ... DNA abnormalities that can occur in a gene called ... kinds of acral and mucosal melanomas, which are less ...
... by Tel Aviv University researcher Prof. Illana Gozes may ... disease. This compound could also treat a number of ... schizophrenia and Parkinson,s, by limiting damage to the brain. ... found to protect American patients with mild cognitive damage ...
... bacteria break their metabolic processes into chunks. That may ... have now figured out the factors that tend to ... Santa Fe Institute and Stanford University, together with Anat ... University, constructed the metabolic networks of many species of ...
... used to prepare a powerful cancer-killing agent may be ... the natural product attacks, according to findings published in ... Chemistry. , Building on their earlier research into neocarzinostatin, ... University of Wisconsin, Madison discovered that one of the ...
Cached Medicine News:Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 2Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 3Health News:OHSU Cancer Instutute researchers find abnormalities in gene for melanoma 2Health News:Appealing the death sentence for brain cells 2Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2
... Rail clamp with self-adjusting adaptability to ... permits complete versatility of angling at the ... The 3/D Swinger permits it to be ... With the Iron Intern®, a simple adjustment ...
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view...
Inquire...
Inquire...
Medicine Products: